The study concluded that there is a significant association of MYBPC3 25-bp deletion polymorphism with elevated risk of LVD (LVEF < 45) (healthy controls v/s LVD: OR = 3.85, p value < 0.001; and non-LVD v/s LVD: OR = 1.65, p value = 0.035), while the other three studied polymorphisms (Myosporin, TNNT2, TTN) do not seem to play a direct role in LVD as well as CAD risk in north Indians [15,16,103,104]. This evidence concerns the gene MYBPC3 and coronary artery disorder.